BIXT Message Board Post 27748640 | Bioxytran Inc
home / stock / bixt / bixt message board
steffanhen570
()
Posted on: Sep/14/2023 22:22:02
Bioxytran, Inc. ($BIXT) is on a mission that goes beyond traditional medical research. They are revolutionizing the treatment landscape by pioneering novel therapies for virology, degenerative diseases, and hypoxia-related conditions. The heart of Bioxytran's work lies in its commitment to addressing significant unmet medical needs. In virology, where emerging viruses pose constant challenges, Bioxytran seeks innovative solutions. In degenerative diseases, they aim to slow down or even reverse the progression of conditions that have long been deemed untreatable. In hypoxia-related disorders, where oxygen deprivation can have devastating effects, Bioxytran strives to provide hope.
News, Short Squeeze, Breakout and More Instantly...
-
BXT-25 is expected to oxygenate the brain BOSTON, MASSACHUSETTS, June 27, 2024 (GLOBE NEWSWIRE) -- BIOXYTRAN, INC. (OTCQB: BIXT) (the “Company”), a clinical stage biotechnology company developing drugs to treat stroke and Alzheimer's disease, announced that Bioxtran’s...
-
X4 Pharmaceuticals Inc. (XFOR) is expected to report $-0.15 for Q4 2023 Li Ning Co., Ltd. ADR (LNNGY) is expected to report for Q4 2023 Xos Inc. (XOS) is expected to report $-2.4 for Q4 2023 PainReform Ltd. (PRFX) is expected to report for quarter end 2023-12-31 Muenchener Rueckve...
-
AIA Group Limited ADR (AAGIY) is expected to report for Q4 2023 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 SecureWorks Corp. (SCWX) is expected to report $-0.15 for Q4 2024 Acacia Research Corporation (ACTG) is expected to report for quarter end...